Genetic Engineering & Biotechnology News

DEC 2018

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link: https://gen.epubxp.com/i/1052771

Contents of this Issue

Navigation

Page 12 of 57

GENengnews.com | Genetic Engineering & Biotechnology News | DECEMBER 2018 | 11 standard testing, such as American Herbal Pharmacopoeia–recognized analytical test methods. It also includes a Lab Manager In- terface that enables managers to modify test requirements (like the specific placement of vials, for example), helping staff maintain internal and external compliance. While testing is underway, the LIMS interfaces directly with instruments. It cap- tures retention times, peak heights, calculat- ed concentrations and other results directly into its database, replacing a time-consum- ing manual step. In addition to capturing live data dur- ing testing, the LIMS undertakes the highly repetitive data analysis that often ties up mindshare in a traditional lab; for example, it will calculate parameters like analyte con- centration using dilution factor and peak data parameter values. That frees analysts to focus on more valuable or complex data science in the lab. Results Are Autogenerated and Reviewed An analyst examines results in the LIMS and provides approval through the eSig fea- ture. A second analyst peer-reviews the data, also providing approval. A lab manager's sign-off is the final step, prompting the sys- tem to generate a CoA which can then be printed. The grower, automatically notified through the LIMS, can access that CoA and other documentation through the same por- tal that facilitated the initial request—here, too, the grower will find a history of test re- sults linked to its account. LIMS Interfaces with METRC and Populates Invoice Early in the testing process, the LIMS sub- mitted sample details to METRC; now, at the completion of testing, it submits results. The LIMS can also autopopulate an in- voice based on an established fee structure, eliminating the administrative friction be- tween lab activities and standalone financial software. From initial request through final invoic- ing, the preconfigured cannabis LIMS works in lockstep with lab teams, enabling a highly efficient and scalable workflow supported by industry-standard quality control. The Purpose-Built LIMS: A Customer's Perspective ChemHistory, an Oregon-based canna- bis testing lab, is currently transitioning to a preconfigured LIMS from LabVantage. Lab director Douglas Duncan sees the system as a fail-safe against costly errors, particularly giv- en the immaturity of cannabis-related meth- odologies relative to other agricultural assays. "The science of cannabis testing is only just emerging," says Duncan. "The instru- mentation isn't optimized for this matrix. That means a lot of data, but not much reli- ability. With the LIMS, we can run ad hoc queries and perform reality checks to im- mediately identify errors. The system also enables a level of inquiry not possible with a human workforce alone; our analysts can leave highly repetitive work of processing raw data to the LIMS and redirect their focus to a depth of statistical analysis that's more valuable for us and for our customers." The ChemHistory LIMS will replace a network of siloed point solutions, harmoniz- ing operations between disparate users and applying a common language throughout the organization, from analysts through ad- ministrators and other nonscientific staff. "I sleep better at night with this system in place," concludes Duncan. "The LIMS provides a level of consistency and redun- dancy that allows me to sign CoAs with con- fidence." Bring A Wide Range of Nucleic Acids Into Focus Get high quality QC analysis for your genomics workflow with the Fragment Analyzer from Agilent Technologies. Its extraordinary sizing accuracy and wide dynamic range can quickly verify the concentration and size of your DNA and RNA samples so you can focus on discovery. Learn more about the Agilent Fragment Analyzer at www.agilent.com For Research Use Only. Not for use in diagnostic procedures. © Agilent Technologies, Inc. 2018 Drug Discovery Figure 2. The Harvest Lot Menu Screen gives growers access to all of their harvest lot requests at various stages of service, from new through historical. Marty Pittman (mpittman@labvantage. com) is a senior product manager at LabVantage Solutions. Website: www.labvantage.com.

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - DEC 2018